0
Editor's Correspondence |

Is Bone Mineral Density Paradoxically Increased in Early Stage of Diabetic Nephropathy?

Hiroyuki Koshiyama, MD, PhD; Kiyoshi Tanaka, MD, PhD; Kazuwa Nakao, MD, PhD
Arch Intern Med. 1999;159(10):1145. doi:.
Text Size: A A A
Published online

Extract

Bone mineral density (BMD) is known to show a progressive loss in end-stage renal failure,1 but there have been few reports about the BMD in early stage of renal failure. We investigated the change of BMD in subjects with early stage of diabetic nephropathy. The BMDs of L2 to L4 were measured with dual-energy x-ray absorptiometry (QDR-4500; Hologic Co, Waltham, Mass), as previously reported,2,3 in 492 Japanese subjects with type 2 diabetes (206 men and 286 women, mean ± SE age, 61.7 ± 0.5 years). Early stage of nephropathy was defined as consistent proteinuria without any increase in serum creatinine level. None of the patients had received glucocorticoid, estrogen, or thiazide, which are known to influence BMD. There was no significant difference in body mass index, age, insulin dosage, or glycemic control (hemoglobin A1c) between the subjects with nephropathy (n=145) and those without (n=347). The mean ± SE BMD values were higher in the subjects with early-stage nephropathy than in those without (0.973 ± 0.016 g/cm2 vs 0.909 ± 0.010 g/cm2; P<.001). The percentage values of BMD compared with age- and sex-matched control data were also higher in the subjects with early-stage nephropathy than in those without (112.0% ± 1.7% vs 105.3% ± 1.0%, P<.001).

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Jobs
JAMAevidence.com

Users' Guides to the Medical Literature
Clinical Resolution

Users' Guides to the Medical Literature
Clinical Scenario

brightcove.createExperiences();